17 documents found, page 1 of 2

Sort by Issue Date

Pericardial fluid accumulates microRNAs that regulate heart fibrosis after myoc...

Silva, Elsa D.; Pereira-Sousa, Daniel; Ribeiro-Costa, Francisco; Cerqueira, Rui; Enguita, Francisco J.; Gomes, Rita N.; Dias-Ferreira, João

Pericardial fluid (PF) has been suggested as a reservoir of molecular targets that can be modulated for efficient repair after myocardial infarction (MI). Here, we set out to address the content of this biofluid after MI, namely in terms of microRNAs (miRs) that are important modulators of the cardiac pathological response. PF was collected during coronary artery bypass grafting (CABG) from two MI cohorts, pati...


Encapsulation of Active Pharmaceutical Ingredients in Lipid Micro/Nanoparticles...

Favaro-Trindade, Carmen S.; Matos Junior, Fernando E. de; Okuro, Paula K.; Dias-Ferreira, João; Cano, Amanda; Severino, Patricia; Zielińska, Aleksandra

Nanoencapsulation via spray cooling (also known as spray chilling and spray congealing) has been used with the aim to improve the functionality, solubility, and protection of drugs; as well as to reduce hygroscopicity; to modify taste and odor to enable oral administration; and many times to achieve a controlled release profile. It is a relatively simple technology, it does not require the use of low-cost solve...


Elastic and Ultradeformable Liposomes for Transdermal Delivery of Active Pharma...

Souto, Eliana; Macedo, Ana S; Dias-Ferreira, João; Cano, Amanda; Zielińska, Aleksandra; Matos, Carla M.

Administration of active pharmaceutical ingredients (APIs) through the skin, by means of topical drug delivery systems, is an advanced therapeutic approach. As the skin is the largest organ of the human body, primarily acting as a natural protective barrier against permeation of xenobiotics, specific strategies to overcome this barrier are needed. Liposomes are nanometric-sized delivery systems composed of phos...


Open-Air Cold Plasma Device Leads to Selective Tumor Cell Cytotoxicity

Almeida-Ferreira, Catarina; Silva-Teixeira, Rafael; Laranjo, Mafalda; Almeida, Nuno; Brites, Gonçalo; Dias-Ferreira, João; Marques, Inês A.; Neves, Rita

The need for effective and safe therapies for cancer is growing as aging is modifying its epidemiology. Cold atmospheric plasma (CAP) has gained attention as a potential anti-tumor therapy. CAP is a gas with enough energy to ionize a significant fraction of its constituent particles, forming equal numbers of positive ions and electrons. Timely-resolved output voltage measurement, emission spectroscopy, and quan...


Carta ao editor: O papel dos estudantes de medicina na pandemia de COVID-19 em ...

Gi, Andreia; Rodrigues, Bárbara; Dias-Ferreira, João; Faria, João; Pedro, João Fernandes; Oliveira, João; Viegas, Maria H.; Ribeiro, Marta


Chemical and Physical Properties of Meadowfoam Seed Oil and Extra Virgin Olive ...

Zielińska, Aleksandra; Wójcicki, Krzysztof; Klensporf-Pawlik, Dorota; Dias-Ferreira, João; Lucarini, Massimo; Durazzo, Alessandra; Lucariello, Giuseppe

In food industry, vegetable oils are commonly used as functional ingredients. Cold pressed oils containing fatty acids show a variety of chemical properties, which are mainly dependent on the saturation of fatty acids. In this study, we have analyzed meadowfoam seed oil (MSO), obtained from seeds of Limnanthes alba, and extra virgin olive oil (EVO). Firstly, the fatty acids composition, denoted as Cox value, wa...


Nanopharmaceutics: Part I-Clinical Trials Legislation and Good Manufacturing Pr...

Souto, Eliana B.; Silva, Gabriela F.; Dias-Ferreira, João; Zielińska, Aleksandra; Ventura, Fátima; Durazzo, Alessandra; Lucarini, Massimo

The latest advances in pharmaceutical technology are leading to the development of cutting edged approaches to produce what is now known as the "Holy Grail" of medicine-nanopharmaceutics. Over the latest decade, the pharmaceutical industry has made important contributions to the scale up of these new products. To ensure their quality, efficacy, and safety for human use, clinical trials are mandatory. Yet, regul...


Chapter 7 - Ethical issues in research and development of nanoparticles

Souto, Eliana B.; Dias-Ferreira, João; Shegokar, Ranjita; Durazzo, Alessandra; Santini, Antonello

Current societal challenges demonstrate the added value of nanotechnology in improving several goods in a set of industries (e.g., pharmaceuticals, nutraceuticals, cosmetics, medical devices). Along with the unprecedent technological developments, ethical issues are posed to scientists, regulators, and users as new materials with new functionalities are being launched that have unforeseen impact in the society....


Nanopharmaceutics: Part IClinical trials legislation and Good Manufacturing Pra...

Souto, Eliana B.; Silva, Gabriela F.; Dias-Ferreira, João; Zielinska, Aleksandra; Ventura, Fátima; Durazzo, Alessandra; Lucarini, Massimo

The latest advances in pharmaceutical technology are leading to the development of cutting edged approaches to produce what is now known as the “Holy Grail” of medicine—nanopharmaceutics. Over the latest decade, the pharmaceutical industry has made important contributions to the scale up of these new products. To ensure their quality, efficacy, and safety for human use, clinical trials are mandatory. Yet, regul...


Nanopharmaceutics: Part II - Production scales and clinically compliant product...

Souto, Eliana B.; Silva, Gabriela F.; Dias-Ferreira, João; Zielinska, Aleksandra; Ventura, Fátima; Durazzo, Alessandra; Lucarini, Massimo

Due the implementation of nanotechnologies in the pharmaceutical industry over the last few decades, new type of cutting-edge formulationsnanopharmaceuticshave been proposed. These comprise pharmaceutical products at the nanoscale, developed from different types of materials with the purpose to, e.g., overcome solubility problems of poorly water-soluble drugs, the pharmacokinetic and pharmacodynamic profiles of...


17 Results

Queried text

Refine Results

Author





















Date





Document Type




Access rights



Resource





Subject